University of Central Florida - Innovative Center
Orlando, Florida, 32826, United States
Location status: Recruiting
NCT Number: NCT06512168
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger & Kent-Walsh).
Interested in participating?
Request Info42 month–60 month
All sexes
Interventional
Not applicable
Orlando, Florida, 32826, United States
Location status: Recruiting
Our central hypotheses are: (1) psychometrically sound measures can be established to capture growth within and across different dimensions of language acquisition, and (2) some elicitation contexts will be better than others at capturing aided language growth. Specific Aim 1 identifies valid measures to characterize aided language progress. Aim 1A uses existing data to document the psychometric properties of a range of aided language measures for preschoolers at the early stages of aided communication acquisition who have received 4 months of aided language intervention. Aim 1B analyzes language progression for high-performing aided communicators who will receive 24 months of intervention; this allows for investigation across all phases of early aided language acquisition. Specific Aim 2 identifies elicitation contexts that demonstrate the most productive aided language use. Achievement of the aims will result in measures that demonstrate strong reliability, differentiate growth for different populations, describe different dimensions of language growth, and are clinically feasible.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aided AAC Language Input/Output Intervention
Time frame: 24 Months
Aided AAC Sentence Length Measured in Morphemes
Contact information is provided by the study sponsor or research team.
Cathy Binger, PhD
CONTACT
Jennifer Kent-Walsh, PhD
CONTACT
University of Central Florida
Other
Acronym: MALD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03538925
Abnormalities, Multiple, Behavior
Orlando, Florida, United States
View Trial DetailsNCT06591559
Abnormalities, Multiple, Brain Damage, Chronic
Seattle, Washington, United States
View Trial DetailsNCT06865248
Abnormalities, Multiple, Brain Damage, Chronic
Famagusta, Cyprus
View Trial DetailsNCT05198232
Abnormalities, Multiple, Autism Spectrum Disorder
Auburn, Alabama, United States
View Trial Details